
Marilyn G. Macasiano
Examiner (ID: 2397, Phone: (571)270-5205 , Office: P/3688 )
| Most Active Art Unit | 3688 |
| Art Unit(s) | 3688, 3622 |
| Total Applications | 654 |
| Issued Applications | 347 |
| Pending Applications | 61 |
| Abandoned Applications | 258 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18108053
[patent_doc_number] => 20230000933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => AGENT FOR PREVENTION OR REMEDIATION OF STRESS DISORDERS AND COMPOSITION CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 17/782136
[patent_app_country] => US
[patent_app_date] => 2020-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782136
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782136 | AGENT FOR PREVENTION OR REMEDIATION OF STRESS DISORDERS AND COMPOSITION CONTAINING SAME | Nov 25, 2020 | Abandoned |
Array
(
[id] => 18110859
[patent_doc_number] => 20230003739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => OPTICAL METHOD FOR DETECTING A TARGET MOLECULE BY MEANS OF THE AMPLIFICATION IN THE INTERFERENCE RESPONSE, RESULTING FROM THE REFRACTIVE INDEX AND DISPERSION
[patent_app_type] => utility
[patent_app_number] => 17/781697
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781697
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781697 | OPTICAL METHOD FOR DETECTING A TARGET MOLECULE BY MEANS OF THE AMPLIFICATION IN THE INTERFERENCE RESPONSE, RESULTING FROM THE REFRACTIVE INDEX AND DISPERSION | Nov 24, 2020 | Pending |
Array
(
[id] => 18649355
[patent_doc_number] => 20230295152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/756243
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17756243
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/756243 | PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS | Nov 19, 2020 | Pending |
Array
(
[id] => 17157269
[patent_doc_number] => 20210318320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => CALIBRATOR FOR IMMUNOASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/952473
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952473
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952473 | CALIBRATOR FOR IMMUNOASSAYS | Nov 18, 2020 | Abandoned |
Array
(
[id] => 18056322
[patent_doc_number] => 20220387408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => USE OF MAST CELL STABILIZER FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION
[patent_app_type] => utility
[patent_app_number] => 17/776075
[patent_app_country] => US
[patent_app_date] => 2020-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776075
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776075 | USE OF MAST CELL STABILIZER FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION | Nov 9, 2020 | Abandoned |
Array
(
[id] => 18034708
[patent_doc_number] => 20220378923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => BET DEGRADER
[patent_app_type] => utility
[patent_app_number] => 17/764883
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 114908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 364
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764883
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764883 | BET DEGRADER | Sep 29, 2020 | Pending |
Array
(
[id] => 17806307
[patent_doc_number] => 20220258142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METALLOSILICATE CATALYST SOLVENT WASH
[patent_app_type] => utility
[patent_app_number] => 17/626156
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626156
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626156 | METALLOSILICATE CATALYST SOLVENT WASH | Sep 28, 2020 | Abandoned |
Array
(
[id] => 17961352
[patent_doc_number] => 20220341933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => A NOVEL COMPLEX FORMED BETWEEN THE FLAVIVIRAL NON-STRUCTURAL NS1 PROTEIN AND PLASMA LIPOPROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/761767
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761767
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761767 | A NOVEL COMPLEX FORMED BETWEEN THE FLAVIVIRAL NON-STRUCTURAL NS1 PROTEIN AND PLASMA LIPOPROTEINS | Sep 24, 2020 | Pending |
Array
(
[id] => 18091375
[patent_doc_number] => 20220409716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => T-CELL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/763548
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763548
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763548 | T-CELL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Sep 23, 2020 | Pending |
Array
(
[id] => 18523011
[patent_doc_number] => 20230233665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => ANTI- SARS-COV-2-INFECTION PROTEIN AND VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/923303
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923303
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923303 | ANTI- SARS-COV-2-INFECTION PROTEIN AND VACCINE | Sep 17, 2020 | Pending |
Array
(
[id] => 18987689
[patent_doc_number] => 20240059658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => QUINOLINE DERIVATIVES AND USES IN MANAGING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/642032
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/642032 | QUINOLINE DERIVATIVES AND USES IN MANAGING CANCER | Sep 9, 2020 | Abandoned |
Array
(
[id] => 17896978
[patent_doc_number] => 20220306640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => HYDANTOIN DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/638375
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638375
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638375 | HYDANTOIN DERIVATIVE | Sep 3, 2020 | Abandoned |
Array
(
[id] => 17837938
[patent_doc_number] => 20220275243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => SURFACE FUNCTIONALIZED SUBSTRATES AND METHODS OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/635572
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635572
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/635572 | SURFACE FUNCTIONALIZED SUBSTRATES AND METHODS OF MAKING THE SAME | Aug 19, 2020 | Pending |
Array
(
[id] => 17836414
[patent_doc_number] => 20220273719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => GENETICALLY MODIFIED NK CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/632877
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632877 | GENETICALLY MODIFIED NK CELLS AND USES THEREOF | Aug 10, 2020 | Abandoned |
Array
(
[id] => 17837686
[patent_doc_number] => 20220274991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => SMALL MOLECULE INHIBITORS OF KU70/80 AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/626995
[patent_app_country] => US
[patent_app_date] => 2020-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626995
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626995 | SMALL MOLECULE INHIBITORS OF KU70/80 AND USES THEREOF | Jul 15, 2020 | Abandoned |
Array
(
[id] => 16569112
[patent_doc_number] => 20210008118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => METHOD FOR ENHANCING MIGRATION OF STEM CELLS INTO CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 16/926015
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16926015
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/926015 | METHOD FOR ENHANCING MIGRATION OF STEM CELLS INTO CANCER CELLS | Jul 9, 2020 | Pending |
Array
(
[id] => 17988893
[patent_doc_number] => 20220354930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => Hemoglobin Substitute Mixtures Including Reconstituted Plasma and Platelets and Their Manufacture and Use
[patent_app_type] => utility
[patent_app_number] => 17/623536
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/623536 | Hemoglobin Substitute Mixtures Including Reconstituted Plasma and Platelets and Their Manufacture and Use | Jul 1, 2020 | Abandoned |
Array
(
[id] => 18055638
[patent_doc_number] => 20220386724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => ANTIMICROBIAL DYES FOR HEALTHCARE APPAREL
[patent_app_type] => utility
[patent_app_number] => 17/624154
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624154
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624154 | ANTIMICROBIAL DYES FOR HEALTHCARE APPAREL | Jun 30, 2020 | Abandoned |
Array
(
[id] => 18065687
[patent_doc_number] => 20220396774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => COMPOSITIONS AND METHODS FOR GENERATING INSULIN-PRODUCING BETA CELLS
[patent_app_type] => utility
[patent_app_number] => 17/622436
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622436
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622436 | COMPOSITIONS AND METHODS FOR GENERATING INSULIN-PRODUCING BETA CELLS | Jun 30, 2020 | Pending |
Array
(
[id] => 18707581
[patent_doc_number] => 20230330158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => INTESTINAL MICROBIOTA BACTERIA AND COMPOSITION CONTAINING SAME FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES CHARACTERISED BY EXCESS 2-HYDROXYGLUTARATE
[patent_app_type] => utility
[patent_app_number] => 17/915610
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915610 | INTESTINAL MICROBIOTA BACTERIA AND COMPOSITION CONTAINING SAME FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES CHARACTERISED BY EXCESS 2-HYDROXYGLUTARATE | Jun 23, 2020 | Abandoned |